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Automation of Assays: Improving Precision and 
Throughput
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Introduction
• Manual immunoassays, especially functional assays 
involving living organisms are inherently variable.
− Assay variability is a consequence of the assay complexity and high 
sensitivity of live organisms to external factors.
− Multiple external factors affecting the assay, such as variability of 
individual techniques between the analysts,  are often hard to 
control.
− Manual assays usually require extensive technical training of 
analysts.
Potential Benefits of Assay Automation
• Numerous potential benefits are considered when the 
possibility of automation in the laboratory are evaluated, 
including:
− improvement of  the quality and reliability of test results;
− increased workplace ergonomics, employee productivity and safety; 
− enhancement of the assay efficiency/throughput;
− standardization of lab techniques;
• Complete automation presents operational and financial 
challenges and is not always economically justifiable; partial 
automation of the process workflow may be beneficial. 
Example 1. 
Automation of the Meningococcal Serum Bactericidal Assay 
(Mn SBA) for Serogroups A, C, Y and W135.
Step 2:  Adding complement (    )
Step 1:  Mixing bacteria with test serum  
Principle of the Serum Bactericidal Assay
Step 3:  Complement-mediated killing (defined as reduction in colony counts)
Manual Mn SBA ACYW135 assay
• Classic Meningococcal Serum Bactericidal Assay. 
− Four individual manual SBAs are performed to measure 
bactericidal antibody titers to Neisseria meningitidis serogroup A, 
C, Y and W135.
− The SBA is a complex assay involving multiple manual dilutions 
performed by analysts.
• Qualification studies were conducted to objectively 
evaluate the  assay parameters and performance.
− The statistical analysis revealed that total variability was higher 
than expected.
• Further analysis demonstrated that among the 
ruggedness factors, the variability associated with 
the analyst showed the highest impact on the assay.
Manual Mn SBA ACYW135 Assay Variability 
• The analysts were producing substantially different 
Serogroup Analyst to Analyst Run within Analyst Total
A 91% 90% 175%
C 15% 74% 100%
W135 29% 39% 65%
Y 19% 34% 74%
Variance estimates (%RSD)
titers 
− Within analyst variability changed from analyst to analyst.
− High variability was observed for both assay controls and test 
samples.
Automation of the sample processing for the Mn SBA 
ACYW135: Hamilton Microlab STAR
Summary of The Mn SBA ACYW135 Automation Effort
• Assay scripts were developed and validated. Scripts 
were created based on the manual process 
described in the SOP.
• The control and sample processing was performed 
by Hamilton.
• The use of the sample master dilution plate enabled 
simultaneous testing of the four serogroups 
improving assay throughput.
Standardize Sample Processing: 
Sample Assay Plate Transfer
MnCMnA MnY MnW
Deck is reloaded 1-2 times dependent on the number of Master 
plates.
Sample Master 
Dilution Plates Sample Assay Plates
Improvement of Overall Assay Precision After the 
Implementation of the Automation Step, per Serogroup





























Automation of Seasonal Influenza HAI
Principle of the Hemagglutination Inhibition Assay 
Hemagglutination
Inhibition of hemagglutination
Seasonal Flu HAI 
• The HAI assay is used to test various seasonal strains of Influenza 
virus
• The assay procedure consists of two analyst serially titrating a sample 
replicate with a 2-fold serial dilution for up to 12 microtiter assay 
plates per analyst, per strain
• Variability is increased because two analysts are generating replicate 
plates (and independent results)











Seasonal FLU HAI: Sample Processing Applications
• Similar to the MnSBA sample processing standardization
• Hamilton automation methods were designed to facilitate the testing of 

































Seasonal Flu HAI: Replicate Repeat Rate Results
Sample Titer



























Improved Biofunctional Assay Variability Conclusions
• Utilizing automation for high throughput sample 
processing applications has improved two of our 
biofunctional assays by reducing:
− Variability and sample retest rate for Mn SBA 
ACYW135
− Variability and sample retest rate for Seasonal Flu 
HAI 




















Each of these steps can be automated
Nucleic Acid Extraction: QIAGEN BioRobot MDx (DNA) 
and BioMèrieux NucliSens easyMAG (RNA)




− Accurate liquid handling
• filtered tips
− On-board vacuum processing 
− Locked down once program 
begins
• The NucliSens easyMAG 
− Automated system 
− Magnetic silica beads
− On-board magnet 
− Requires little hands-on 
interaction during a run
Increased Efficiencies – DNA and RNA Extraction
• Manual DNA Extraction 
(QIAGEN Blood Kit)
− 6 hours touch time = 384 
samples
• Automated Extraction 
(Qiagen BioRobot MDx)
− 3 hours touch time = 1152 
samples
• QIAGEN Manual Method
− 4.5 hours touch time = 72 
samples
− OR
• Boom Silica Manual Method
− 5 hours touch time = 48 
samples
• BioMèrieux NucliSens 
easyMAG 
− 3 hours touch time = 144
samples
Automation of Sample Processing by TECAN Freedom 
Evo
• The TECAN Freedom Evo 
− Automated liquid handling system 
− Highly accurate pipetting
− Decreased cross-contamination
− Can be customized 
• Different arm configurations 
• Integration of other lab equipment.
• The Molecular Testing Laboratory at PPD VBL utilizes two 
separate Freedom Evo configurations to maximize the sample 
preparation potential of our high throughout PCR process.
• TECAN Freedom Evo can process 50 assay plates/FTE/Day 
with 1.5-2 h of touch time, resulting in a throughput of
− Up to 200 plates per day
− Or approximately 6 times the throughput of a single analyst
Principle of a Singleplex PCR assay
Throughput calculation,
Example for 90 samples:
• 1 plate
• 15 different strains/organisms
• 3 Open Reading Frames
• 45 Assay Plates
Primers and probe anneal
Denature template DNA 
Gene of interest
• 1.5 FTE
As Taq extends, 
proximity of reporter dye 
to quencher dye is lost 
and fluorescent signal is 
generated for the product 
of amplification produced
Principle of a Multiplex PCR assay
Throughput calculation
Example for 90 samples:
• 1 plate
• 15 different strains/organisms
• 3 Open Reading Frames 
measured simultaneously
• 15 Assay Plates
Primers and probe anneal
Denature template DNA 
Gene 1 Gene 2 Gene 3
• 0.5 FTE
• Note: Target genes may 
come from the same or a 
different organism.
As Taq extends, 
proximity of reporter dye 
to quencher dye is lost 
and a different 
fluorescent signal is 
generated for each of the 
amplification produced



















• Typical characteristics of the assay:
− The assay is linear over 6 logarithms of concentration
− Each target is amplified equivalently













20 Gene 3 
1 2 3 4 5 6
Benefits of Automating and Multiplexing of the Assays
• Increases quality of the data compared to manual 
assays (reduces error rate, including sample dilutions, placement, 
cross-contamination, etc.)
• Increases assay throughput
• Increases the assay development flexibility
− Combination of different targets (i.e. antigens) can be tested 
simultaneously
• Improves assay parameters
− Simultaneous detection of different targets to enhance specificity 




Considerations to be taken into account when automating 
an assay 
• Why is automation required? What is the reason for 
automating a process? What is this going to achieve for 
the laboratory?
− What is the testing volume?
− What are the potential benefits (throughput, retest 
rate, precision)?
• How much automation is required? Is a fully 
automated system needed or a semi-automated 
system?
• What systems are available?
Potential drawbacks of automation
• Once that step is taken it is very hard to remove 
automation from a laboratory. It becomes a part of 
the validated process.
• Logistical issues. In partial automation (automation 
of individual steps) balancing the throughput of 
different steps and eliminating bottlenecks may be 
challenging.
• Re-training of personnel is needed.
• Significant upfront investment may be required.
Step 2:  Adding complement (    )
Step 1:  Mixing bacteria with test serum  
Principle of the Serum Bactericidal Assay
Step 3:  Complement-mediated killing (defined as reduction in colony counts)
Variability: Summary for SBAs
Variance Estimates (%RSD)

















A 1 10% 0% 44% 0% 5% 31%
C 86% 19% 103% 18% 20% 44%
W 0% 18% 35% 2% 4% 19%
Y 14% 13% 34% 0% 16% 23%
A 2 256% 20% 337% 49% 0% 59%
C 98% 29% 140% 17% 12% 33%
W 78% 9% 97% 0% 11% 20%
Y 41% 28% 83% 0% 0% 16%
A 3 20% 0% 74% 2% 10% 20%
C 6% 19% 41% 9% 13% 29%
W 26% 13% 41% 44% 8% 52%
Y 38% 65% 145% 0% 0% 23%
Standardize Sample Processing: 
Sample Master Dilution Plates
Samples Master Dilution Plates
Standardize Sample Processing: 
Sample Assay Plate Transfer
MnCMnA MnY MnW
Deck is reloaded 1-2 times dependent on the number of Master 
plates.
Sample Master 
Dilution Plates Sample Assay Plates
Improvement of Overall Assay Precision After the 














































Improvement of Overall Assay Precision After the 














































Serotype W135   
Applied Biosystem 3730xl DNA Analyzer-Sequencing
• The ABI 3730xl DNA 
Analyzer 
− Fully automated sequence 
analyzer
− 16-plate stacker 
− Monitoring software 
• will alert an analyst of any 
errors
Increased Efficiencies - Sequencing
• GE MegaBACE 1000
− Assay 1 = 3.0 hour run / 96-well plate
• Plus 30 minutes touch time / plate
− Max three 96-well plates / day
• 288 samples
− 1 FTE, 1.5 hours touch time




− Assay 1 and 2 = 2 hour run / 96-well 
plate
• Miniscule amount of touch time to load 
run settings
− Max 12 plates in 24 hours
• 1, 152 samples
− 1 FTE, 30 mins touch time
− Assay 2 = 5.0 hour run / 96-well plate
• Plus 30 minutes touch time / plate
− Max two 96-well plates / day
• 192 samples
− 1 FTE, 1.0 hours touch time
• 1.0 hours touch time = 192 
samples
• 30 minutes touch time = 1, 152 
samples
− Friday Night
− Max 16 plates / stacker 
• 1, 536 samples
− 1 FTE, 30 mins touch time
• 30 minutes touch time = 1, 536 
samples
Improvement of Analyst-related Variability After 
Implementation of the Automation Step





Variability (%RSD) Attibuted to Analyst





Fold-Difference in Titer Between Analysts
Benefits of Automating Immunoassays
• A contemporary immunoassay used for clinical trials 
is typically a complex multistep process which is 
qualified and validated.
• Automation of the most labor intensive and manual 
steps of immunoassays often improves assay 
precision and reduces the possibility of costly human 
errors.
• Automated liquid handling technology should be 
incorporated in the assay workflow as early as 
possible, ideally, at the development stage.
